Heart Test Laboratories, Inc. (HSCS)
NASDAQ: HSCS · IEX Real-Time Price · USD
2.02
+0.21 (11.60%)
At close: Jun 24, 2022 4:00 PM
2.04
+0.02 (0.99%)
Pre-market:
Jun 27, 2022 7:01 AM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Year | 2020 | 2019 |
|---|---|---|
|
Revenue
|
0.03 | 0.06 |
|
Revenue Growth (YoY)
|
-60.11% | - |
|
Cost of Revenue
|
0.01 | 0.05 |
|
Gross Profit
|
0.01 | 0.02 |
|
Selling, General & Admin
|
0.87 | 1.8 |
|
Research & Development
|
1.71 | 2.04 |
|
Operating Expenses
|
2.58 | 3.84 |
|
Operating Income
|
-2.57 | -3.82 |
|
Interest Expense / Income
|
0.13 | 0 |
|
Other Expense / Income
|
-0.25 | -0.01 |
|
Pretax Income
|
-2.45 | -3.81 |
|
Net Income
|
-2.45 | -3.81 |
|
Net Income Common
|
-2.45 | -3.81 |
|
Shares Outstanding (Basic)
|
3 | 3 |
|
Shares Outstanding (Diluted)
|
3 | 3 |
|
Shares Change
|
0.00% | - |
|
EPS (Basic)
|
-0.74 | -1.15 |
|
EPS (Diluted)
|
-0.74 | -1.15 |
|
Free Cash Flow Per Share
|
-0.74 | -1.16 |
|
Gross Margin
|
58.35% | 27.61% |
|
Operating Margin
|
-10030.18% | -5948.99% |
|
Profit Margin
|
-9577.29% | -5937.99% |
|
Free Cash Flow Margin
|
-9580.56% | -5970.25% |
|
EBITDA
|
-2.29 | -3.74 |
|
EBITDA Margin
|
-8928.70% | -5834.16% |
|
Depreciation & Amortization
|
0.03 | 0.06 |
|
EBIT
|
-2.32 | -3.81 |
|
EBIT Margin
|
-9059.98% | -5933.61% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).